{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:46:42Z","timestamp":1789552002246,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,3]],"date-time":"2023-12-03T00:00:00Z","timestamp":1701561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ygyno.2023.11.026","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T08:31:12Z","timestamp":1702369872000},"page":"111-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Genomic characterization of vulvar squamous cell carcinoma reveals differential gene expression based on clinical outcome"],"prefix":"10.1016","volume":"180","author":[{"given":"Mary E.","family":"Gordinier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey F.","family":"Schau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanna B.","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa B.E.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Talwalkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2023.11.026_bb0005","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ygyno.2020.06.482","article-title":"Genomic characterization of vulvar squamous cell carcinoma","volume":"158","author":"Prieske","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.critrevonc.2011.09.003","article-title":"Clinico-pathological and biological prognostic variables in squamous cell carcinoma of the vulva","volume":"83","author":"Gadducci","year":"2012","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0020","author":"National Comprehensive Cancer Network"},{"key":"10.1016\/j.ygyno.2023.11.026_bb0025","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00000421-198904000-00011","article-title":"Mitoxantrone in the treatment of advanced vulvar and vaginal carcinoma. A gynecologic oncology group study","volume":"12","author":"Muss","year":"1989","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0030","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/0090-8258(86)90138-1","article-title":"Phase II trials of cisplatin and piperazinedione in advanced or recurrent squamous cell carcinoma of the vulva: a gynecologic oncology group study","volume":"23","author":"Thigpen","year":"1986","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0035","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/annonc\/mdp043","volume":"20","author":"Witteveen","year":"2009","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0040","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ygyno.2017.11.006","article-title":"Prognostic factors for local recurrence of squamous cell carcinoma of the vulva: a systematic review","volume":"148","author":"Te Grootenhuis","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0045","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.18632\/oncotarget.26797","article-title":"Clinical validation of the tempus xT next-generation targeted oncology sequencing assay","volume":"10","author":"Beaubier","year":"2019","journal-title":"Oncotarget."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0050","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/s41587-019-0259-z","article-title":"Integrated genomic profiling expands clinical options for patients with cancer","volume":"37","author":"Beaubier","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0055","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.3390\/cells9091996","article-title":"Transglutaminase 3: the involvement in epithelial differentiation and cancer","volume":"9","author":"Chermnykh","year":"2020","journal-title":"Cells."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0060","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/hed.20598","article-title":"Tumor-specific genetic expression profile of metastatic oral squamous cell carcinoma","volume":"29","author":"Mendez","year":"2007","journal-title":"Head Neck"},{"key":"10.1016\/j.ygyno.2023.11.026_bb0065","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/ijc.24194","article-title":"Transglutaminase 3 as a prognostic biomarker in esophageal cancer revealed by proteomics","volume":"124","author":"Uemura","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2023.11.026_bb0070","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1476-4598-12-151","article-title":"TGM3, a candidate tumor suppressor gene, contributes to human head and neck cancer","volume":"12","author":"Wu","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ygyno.2023.11.026_bb0075","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.humpath.2016.05.020","article-title":"Pathologic features of aggressive vulvar carcinoma are associated with epithelial-mesenchymal transition","volume":"56","author":"Holthoff","year":"2016","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0080","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.devcel.2008.05.009","article-title":"Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis","volume":"14","author":"Yang","year":"2008","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ygyno.2023.11.026_bb0085","first-page":"864","article-title":"TGM3 functions as a tumor suppressor by repressing epithelial-to-mesenchymal transition and PI3K\/AKT signaling pathway in colorectal cancer","volume":"43","author":"Feng","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0090","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ygyno.2020.05.034","article-title":"Genes, pathways and vulvar carcinoma - new insights from next-generation sequencing studies","volume":"158","author":"Zieba","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0095","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1590\/1678-4685-gmb-2017-0332","article-title":"Does the expression of the ACVR2A gene affect the development of colorectal cancer?","volume":"42","author":"Wodzinski","year":"2019","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0100","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.2147\/OTT.S247757","article-title":"Microsatellite instability-related ACVR2A mutations partially account for decreased lymph node metastasis in MSI-H gastric cancers","volume":"13","author":"Zhao","year":"2020","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0105","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.265","article-title":"Mutational signatures and chromosome alteration profiles of squamous cell carcinomas of the vulva","volume":"50","author":"Han","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ygyno.2023.02.006","article-title":"ROS1 as a possible prognostic biomarker of cervical adenocarcinoma: an exploratory analysis with next-generation sequencing","volume":"171","author":"Machida","year":"2023","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0115","doi-asserted-by":"crossref","first-page":"7069","DOI":"10.3390\/ijms22137069","article-title":"Molecular landscape of vulvar squamous cell carcinoma","volume":"22","author":"Carreras-Dieguez","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0120","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/PGP.0000000000000742","article-title":"Targeted molecular sequencing of recurrent and multifocal non-HPV-associated squamous cell carcinoma of the vulva","volume":"40","author":"Pors","year":"2020","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0125","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41379-021-00942-3","article-title":"Molecular landscape of vulvovaginal squamous cell carcinoma: new insights into molecular mechanisms of HPV-associated and HPV-independent squamous cell carcinoma","volume":"35","author":"Salama","year":"2022","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0130","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41379-020-00651-3","article-title":"Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome","volume":"34","author":"Tessier-Cloutier","year":"2021","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0135","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ygyno.2014.11.002","article-title":"Genetic and epigenetic changes in vulvar squamous cell carcinoma and its precursor lesions: a review of the current literature","volume":"136","author":"Trietsch","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2023.11.026_bb0140","first-page":"32","article-title":"Vulvar squamous cell carcinoma: comprehensive genomic profiling of HPV+ versus HPV- forms reveals distinct sets of potentially actionable molecular targets","volume":"159","author":"Williams","year":"2020","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0145","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/S0090-8258(22)01267-7","article-title":"The genomic landscape of vulvovaginal squamous cell carcinoma","volume":"166","author":"Wallbillich","year":"2022","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0150","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00428-018-2364-7","article-title":"PD-L1 receptor expression in vulvar carcinomas is HPV-independent","volume":"473","author":"Choschzick","year":"2018","journal-title":"Virchows Arch."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0155","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00432-020-03126-9","article-title":"PD-L1 expression and survival in p16-negative and -positive squamous cell carcinomas of the vulva","volume":"146","author":"Czogalla","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0160","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s00432-020-03226-6","article-title":"Molecular pathways in vulvar squamous cell carcinoma: implications for target therapeutic strategies","volume":"146","author":"Mantovani","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0165","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.19.00739","article-title":"Safety and efficacy of nivolumab monotherapy in recurrent or metastatic cervical, vaginal, or vulvar carcinoma: results from the phase I\/II CheckMate 358 trial","volume":"37","author":"Naumann","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0170","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000491090","article-title":"Pembrolizumab in recurrent aquamous cell carcinoma of the vulva: case report and review of the literature","volume":"84","author":"Shields","year":"2019","journal-title":"Gynecol. Obstet. Invest."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0175","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ygyno.2022.01.029","article-title":"Efficacy and safety of pembrolizumab for patients with previously treated advanced vulvar squamous cell carcinoma: results from the phase 2 KEYNOTE-158 study","volume":"166","author":"Shapira-Frommer","year":"2022","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0180","doi-asserted-by":"crossref","first-page":"6781","DOI":"10.1158\/1078-0432.CCR-17-1302","article-title":"Genomic characterization of vulvar (pre)cancers identifies distinct molecular subtypes with prognostic significance","volume":"23","author":"Nooij","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0185","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ajog.2020.12.1220","article-title":"p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynakologische Onkologie chemo and radiotherapy in epithelial vulvar Cancer study group","volume":"224","author":"Woelber","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0190","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ygyno.2011.05.016","article-title":"Does human papillomavirus infection imply a different prognosis in vulvar squamous cell carcinoma?","volume":"122","author":"Alonso","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0195","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ygyno.2018.06.026","article-title":"Somatic mutation profiling of vulvar cancer: exploring therapeutic targets","volume":"150","author":"Zieba","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.11.026_bb0200","doi-asserted-by":"crossref","first-page":"S251","DOI":"10.1016\/S0090-8258(21)01128-8","article-title":"Racial disparities in the incidence of vulvar cancer in the United States: a study of 75,767 over 16 years","volume":"162","author":"Liao","year":"2021","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823015718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823015718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:54:19Z","timestamp":1715820859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825823015718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":40,"alternative-id":["S0090825823015718"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.11.026","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genomic characterization of vulvar squamous cell carcinoma reveals differential gene expression based on clinical outcome","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.11.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}